Anthony D. Elias, MD, on Triple-Negative Breast Cancer: Treatment Update

NCCN 2018 Annual Conference
Tweet this page

Anthony D. Elias, MD, of the University of Colorado Cancer Center, reviews promising experimental treatments, as well as PARP inhibitor therapy in TNBC, including the implications of newly approved olaparib for gBRCA-mutant breast cancer.

Advertisement

Advertisement



Advertisement